NCT03194074

Brief Summary

Postoperative cognitive impairment is one of the most common complications in elderly surgical patients. Laser laryngeal surgery is a short procedure, but characterized by high risk of disastrous airway fire. So the recommended oxygen concentration is less than 30%. For elderly patients, because of preoperatively declined cardiovascular and lung function and cognitive function, there is a potential that intraoperative low oxygen concentration may lead to drop of arterial oxygen tension, decrease of brain oxygenation, and exacerbate brain function impairment. Intravenous anesthesia and inhalation anesthesia is two commonly used technique for general anesthesia. Consequently, we carry out this study to identify whether different classes of anesthetics can affect postoperative cognitive function in old patient undergoing laser laryngeal surgery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Aug 2017

Typical duration for phase_4

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 17, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 21, 2017

Completed
2 months until next milestone

Study Start

First participant enrolled

August 15, 2017

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2019

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

July 27, 2018

Status Verified

July 1, 2018

Enrollment Period

1.8 years

First QC Date

June 17, 2017

Last Update Submit

July 26, 2018

Conditions

Keywords

Laser Laryngeal SurgeryDesfluranePropofol

Outcome Measures

Primary Outcomes (1)

  • Change of Mini-Mental State (MMS) test score

    Change of 30-point questionnaire that is used to measure cognitive impairment before and after surgery

    Change of MMS score between two time points (the day before surgery and 30min postoperatively

Secondary Outcomes (3)

  • Change of Mini-Mental State (MMS) test score

    Change of MMS score between two time points (the day before surgery and 1h postoperatively

  • Change of Mini-Mental State (MMS) test score

    Change of MMS score between two time points (the day before surgery and 3h postoperatively

  • Change of Mini-Mental State (MMS) test score

    Change of MMS score between two time points (the day before surgery and 24h postoperatively

Study Arms (2)

propofol group

EXPERIMENTAL

Propofol/remifentanil-based general anesthesia.

Drug: Propofol

desflurane group

EXPERIMENTAL

Desflurane/remifentanil-based general anesthesia.

Drug: Desflurane

Interventions

In propofol/remifentanil group, propofol at a rate 75\~150 µg/kg/min and remifentanil at 0.1-0.3 µg/kg/min are maintained throughout surgery.

Also known as: Propofol injection from AstraZeneca
propofol group

In desflurane/remifentanil group, desflurane at end tidal concentration at 0.7\~1.0 minimum alveolar concentration (MAC) and remifentanil 0.1-0.3 ug/kg/min are used.

Also known as: Suprane from Baxter
desflurane group

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients scheduled for laser laryngeal surgery under general anesthesia with either Propofol or desflurane based technique.

You may not qualify if:

  • Patients with cardiac, pulmonary, hepatic, or renal dysfunction, epilepsy, or uncontrolled hypertension, or those taking medications that influence the central nervous system, are excluded from the study. Patients who show obvious alteration of mental status, or refuse to participate, are also excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Otorhinolaryngology Department of Affiliated Eye and ENT Hospital, Fudan University, Shanghai, China

Shanghai, Shanghai Municipality, 200031, China

RECRUITING

Related Publications (4)

  • Evered L, Scott DA, Silbert B, Maruff P. Postoperative cognitive dysfunction is independent of type of surgery and anesthetic. Anesth Analg. 2011 May;112(5):1179-85. doi: 10.1213/ANE.0b013e318215217e. Epub 2011 Apr 7.

    PMID: 21474666BACKGROUND
  • Larsen B, Seitz A, Larsen R. Recovery of cognitive function after remifentanil-propofol anesthesia: a comparison with desflurane and sevoflurane anesthesia. Anesth Analg. 2000 Jan;90(1):168-74. doi: 10.1097/00000539-200001000-00035.

    PMID: 10624999BACKGROUND
  • Royse CF, Andrews DT, Newman SN, Stygall J, Williams Z, Pang J, Royse AG. The influence of propofol or desflurane on postoperative cognitive dysfunction in patients undergoing coronary artery bypass surgery. Anaesthesia. 2011 Jun;66(6):455-64. doi: 10.1111/j.1365-2044.2011.06704.x. Epub 2011 Apr 18.

    PMID: 21501129BACKGROUND
  • Roy S, Smith LP. Surgical fires in laser laryngeal surgery: are we safe enough? Otolaryngol Head Neck Surg. 2015 Jan;152(1):67-72. doi: 10.1177/0194599814555853. Epub 2014 Oct 24.

    PMID: 25344591BACKGROUND

MeSH Terms

Interventions

PropofolDesflurane

Intervention Hierarchy (Ancestors)

PhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic ChemicalsEthyl EthersEthersMethyl EthersHydrocarbons, FluorinatedHydrocarbons, Halogenated

Study Officials

  • Xia Shen, M.D.

    Eye and ENT Hospital of Fudan University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Xia Shen, M.D.

CONTACT

Hui Qiao, M.D.

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Vise Director of Department of Anesthesiology

Study Record Dates

First Submitted

June 17, 2017

First Posted

June 21, 2017

Study Start

August 15, 2017

Primary Completion

June 1, 2019

Study Completion

December 1, 2019

Last Updated

July 27, 2018

Record last verified: 2018-07

Data Sharing

IPD Sharing
Will not share

Locations